Elizabeth Balta - 13 Feb 2023 Form 4 Insider Report for Icosavax, Inc.

Reporting relationship: General Counsel & Corp. Sec.
Issuer ticker: N/A
Reported as of: 13 Feb 2023
Net transaction value: -$63,322
SEC form: 4
Accepted by SEC: 15 Feb 2023, 19:12:48 UTC
Prior SEC filing: 14 Nov 2022
Next SEC filing: 17 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Bekiroglu

Key filing fact

Elizabeth Balta filed Form 4 for Icosavax, Inc. on 15 Feb 2023.

Key facts

This page summarizes Elizabeth Balta's Form 4 filing for Icosavax, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Feb 2023, 19:12.

Change

Previous filing in this sequence was filed on 14 Nov 2022.
Current net transaction value: -$63,322.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICVX transaction

Common Stock

Sale

Transaction value: $63,322
Shares: -5,922
Change %: -5.4%
Price: $10.69
Shares after: 103,007
Date: 13 Feb 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover the applicable withholding taxes upon settlement of restricted stock units issued to the Reporting Person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.41 to $11.02. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.